【表紙】

 

【提出書類】

四半期報告書

【根拠条文】

金融商品取引法第24条の4の7第1項

【提出先】

関東財務局長

【提出日】

2024年2月9日

【四半期会計期間】

第24期第3四半期(自 2023年10月1日 至 2023年12月31日)

【会社名】

エムスリー株式会社

【英訳名】

M3, Inc.

【代表者の役職氏名】

代表取締役社長  谷 村   格

【本店の所在の場所】

東京都港区赤坂一丁目11番44号

【電話番号】

03(6229)8900(代表)

【事務連絡者氏名】

執行役員     大 場   啓 史

【最寄りの連絡場所】

東京都港区赤坂一丁目11番44号

【電話番号】

03(6229)8900(代表)

【事務連絡者氏名】

執行役員     大 場   啓 史

【縦覧に供する場所】

株式会社東京証券取引所

(東京都中央区日本橋兜町2番1号)

 

E05425 24130 エムスリー株式会社 M3, Inc. 企業内容等の開示に関する内閣府令 第四号の三様式 IFRS true CTE 2023-04-01 2023-12-31 Q3 2024-03-31 2022-04-01 2022-12-31 2023-03-31 1 false false false E05425-000 2023-04-01 2023-12-31 jpcrp040300-q3r_E05425-000:SiteSolutionReportableSegmentMember E05425-000 2022-04-01 2022-12-31 jpcrp040300-q3r_E05425-000:SiteSolutionReportableSegmentMember E05425-000 2022-04-01 2022-12-31 jpcrp040300-q3r_E05425-000:OtherEmergingBusinessMember E05425-000 2022-04-01 2022-12-31 jpcrp_cor:ReportableSegmentsMember E05425-000 2022-04-01 2022-12-31 jpcrp040300-q3r_E05425-000:OverseasReportableSegmentMember E05425-000 2022-04-01 2022-12-31 jpcrp040300-q3r_E05425-000:CareerSolutionReportableSegmentMember E05425-000 2022-04-01 2022-12-31 jpcrp040300-q3r_E05425-000:EvidenceSolutionReportableSegmentMember E05425-000 2022-04-01 2022-12-31 jpcrp040300-q3r_E05425-000:MedicalPlatformReportableSegmentMember E05425-000 2023-04-01 2023-12-31 jpcrp_cor:ReconcilingItemsMember E05425-000 2023-04-01 2023-12-31 jpcrp040300-q3r_E05425-000:OtherEmergingBusinessMember E05425-000 2023-04-01 2023-12-31 jpcrp_cor:ReportableSegmentsMember E05425-000 2023-04-01 2023-12-31 jpcrp040300-q3r_E05425-000:OverseasReportableSegmentMember E05425-000 2023-04-01 2023-12-31 jpcrp040300-q3r_E05425-000:CareerSolutionReportableSegmentMember E05425-000 2023-04-01 2023-12-31 jpcrp040300-q3r_E05425-000:EvidenceSolutionReportableSegmentMember E05425-000 2023-04-01 2023-12-31 jpcrp040300-q3r_E05425-000:MedicalPlatformReportableSegmentMember E05425-000 2022-04-01 2022-12-31 jpcrp_cor:ReconcilingItemsMember E05425-000 2023-12-31 jpigp_cor:NonControllingInterestsIFRSMember E05425-000 2023-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E05425-000 2023-12-31 jpigp_cor:RetainedEarningsIFRSMember E05425-000 2023-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E05425-000 2023-12-31 jpigp_cor:TreasurySharesIFRSMember E05425-000 2023-12-31 jpigp_cor:CapitalSurplusIFRSMember E05425-000 2023-12-31 jpigp_cor:ShareCapitalIFRSMember E05425-000 2023-04-01 2023-12-31 jpigp_cor:NonControllingInterestsIFRSMember E05425-000 2023-04-01 2023-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E05425-000 2023-04-01 2023-12-31 jpigp_cor:RetainedEarningsIFRSMember E05425-000 2023-04-01 2023-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E05425-000 2023-04-01 2023-12-31 jpigp_cor:TreasurySharesIFRSMember E05425-000 2023-04-01 2023-12-31 jpigp_cor:CapitalSurplusIFRSMember E05425-000 2023-04-01 2023-12-31 jpigp_cor:ShareCapitalIFRSMember E05425-000 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember E05425-000 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E05425-000 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember E05425-000 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E05425-000 2023-03-31 jpigp_cor:TreasurySharesIFRSMember E05425-000 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember E05425-000 2023-03-31 jpigp_cor:ShareCapitalIFRSMember E05425-000 2022-12-31 jpigp_cor:NonControllingInterestsIFRSMember E05425-000 2022-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E05425-000 2022-12-31 jpigp_cor:RetainedEarningsIFRSMember E05425-000 2022-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E05425-000 2022-12-31 jpigp_cor:TreasurySharesIFRSMember E05425-000 2022-12-31 jpigp_cor:CapitalSurplusIFRSMember E05425-000 2022-12-31 jpigp_cor:ShareCapitalIFRSMember E05425-000 2022-04-01 2022-12-31 jpigp_cor:NonControllingInterestsIFRSMember E05425-000 2022-04-01 2022-12-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E05425-000 2022-04-01 2022-12-31 jpigp_cor:RetainedEarningsIFRSMember E05425-000 2022-04-01 2022-12-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E05425-000 2022-04-01 2022-12-31 jpigp_cor:TreasurySharesIFRSMember E05425-000 2022-04-01 2022-12-31 jpigp_cor:CapitalSurplusIFRSMember E05425-000 2022-04-01 2022-12-31 jpigp_cor:ShareCapitalIFRSMember E05425-000 2022-03-31 jpigp_cor:NonControllingInterestsIFRSMember E05425-000 2022-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember E05425-000 2022-03-31 jpigp_cor:RetainedEarningsIFRSMember E05425-000 2022-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember E05425-000 2022-03-31 jpigp_cor:TreasurySharesIFRSMember E05425-000 2022-03-31 jpigp_cor:CapitalSurplusIFRSMember E05425-000 2022-03-31 jpigp_cor:ShareCapitalIFRSMember E05425-000 2024-02-09 jpcrp_cor:OrdinaryShareMember E05425-000 2023-12-31 jpcrp_cor:SharesWithNoVotingRightsMember E05425-000 2023-12-31 jpcrp_cor:SharesWithRestrictedVotingRightsTreasurySharesEtcMember E05425-000 2023-12-31 jpcrp_cor:SharesWithRestrictedVotingRightsOtherMember E05425-000 2023-12-31 jpcrp_cor:SharesWithFullVotingRightsTreasurySharesEtcMember E05425-000 2023-12-31 jpcrp_cor:OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember E05425-000 2023-12-31 jpcrp_cor:SharesWithFullVotingRightsOtherMember E05425-000 2023-12-31 jpcrp_cor:OrdinarySharesSharesWithFullVotingRightsOtherMember E05425-000 2023-12-31 jpcrp_cor:SharesLessThanOneUnitMember E05425-000 2023-12-31 jpcrp_cor:OrdinarySharesSharesLessThanOneUnitMember E05425-000 2023-12-31 jpcrp_cor:Row1Member E05425-000 2024-02-09 E05425-000 2023-12-31 E05425-000 2023-04-01 2023-12-31 E05425-000 2022-12-31 E05425-000 2022-04-01 2022-12-31 E05425-000 2023-03-31 E05425-000 2022-04-01 2023-03-31 E05425-000 2022-03-31 E05425-000 2023-10-01 2023-12-31 E05425-000 2022-10-01 2022-12-31 E05425-000 2022-10-01 2022-12-31 jpcrp_cor:ReportableSegmentsMember E05425-000 2022-10-01 2022-12-31 jpcrp040300-q3r_E05425-000:MedicalPlatformReportableSegmentMember E05425-000 2022-10-01 2022-12-31 jpcrp040300-q3r_E05425-000:EvidenceSolutionReportableSegmentMember E05425-000 2022-10-01 2022-12-31 jpcrp040300-q3r_E05425-000:CareerSolutionReportableSegmentMember E05425-000 2022-10-01 2022-12-31 jpcrp040300-q3r_E05425-000:SiteSolutionReportableSegmentMember E05425-000 2022-10-01 2022-12-31 jpcrp040300-q3r_E05425-000:OverseasReportableSegmentMember E05425-000 2022-10-01 2022-12-31 jpcrp040300-q3r_E05425-000:OtherEmergingBusinessMember E05425-000 2022-10-01 2022-12-31 jpcrp_cor:ReconcilingItemsMember E05425-000 2023-10-01 2023-12-31 jpcrp_cor:ReportableSegmentsMember E05425-000 2023-10-01 2023-12-31 jpcrp040300-q3r_E05425-000:MedicalPlatformReportableSegmentMember E05425-000 2023-10-01 2023-12-31 jpcrp040300-q3r_E05425-000:EvidenceSolutionReportableSegmentMember E05425-000 2023-10-01 2023-12-31 jpcrp040300-q3r_E05425-000:CareerSolutionReportableSegmentMember E05425-000 2023-10-01 2023-12-31 jpcrp040300-q3r_E05425-000:SiteSolutionReportableSegmentMember E05425-000 2023-10-01 2023-12-31 jpcrp040300-q3r_E05425-000:OverseasReportableSegmentMember E05425-000 2023-10-01 2023-12-31 jpcrp040300-q3r_E05425-000:OtherEmergingBusinessMember E05425-000 2023-10-01 2023-12-31 jpcrp_cor:ReconcilingItemsMember iso4217:JPY xbrli:shares iso4217:JPY xbrli:shares xbrli:pure